Approach to radiation therapy in the Jehovah's Witness patient: An overview

James M. Jurica, Jay A. Messer, Bin S. Teh, E. Brian Butler, Andrew M. Farach

Research output: Contribution to journalReview articlepeer-review


Jehovah's Witnesses are well-known in the medical community for their inability to accept blood products. Novel methods of treatment are often needed to avoid anemia and hematologic toxicity as inability to receive blood products may increase the risk of treatment related complications. We provide an overview of radiation treatment for Jehovah's Witness patients with an emphasis on bone marrow sparing strategies with intensity modulated radiation therapy (IMRT) to minimize hematologic toxicity.

Original languageEnglish (US)
Pages (from-to)856-859
Number of pages4
JournalReports of Practical Oncology and Radiotherapy
Issue number6
StatePublished - Nov 1 2020


  • Anemia
  • Bone marrow sparing
  • Hematologic toxicity
  • Jehovah witness
  • Radiation oncology

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging


Dive into the research topics of 'Approach to radiation therapy in the Jehovah's Witness patient: An overview'. Together they form a unique fingerprint.

Cite this